AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2016

Jan 16, 2016

31046_dirs_2016-01-15_dbe1ca46-fbb9-4701-bd3d-d31fdc8682bc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-10-20

Reporting Person: Rothera Mark (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-20	Common Stock	G	9216	—	Disposed	0	Direct
2015-10-20	Common Stock	G	9216	—	Acquired	9216	Indirect

Footnotes

F1: This transaction involved a bona fide gift of securities by the reporting person to a trust of which the reporting person's spouse is a beneficiary.